Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Short-Term Debt issuances (2018 - 2025)

Historic Short-Term Debt issuances for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Q3 2025 value amounting to $172000.0.

  • Amphastar Pharmaceuticals' Short-Term Debt issuances fell 9819.1% to $172000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 2126.57%. This contributed to the annual value of $18.4 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Short-Term Debt issuances of $172000.0 as of Q3 2025, which was down 9819.1% from $4.1 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Short-Term Debt issuances' 5-year high stood at $500.0 million during Q2 2023, with a 5-year trough of -$25000.0 in Q2 2024.
  • Moreover, its 3-year median value for Short-Term Debt issuances was $4.1 million (2024), whereas its average is $65.5 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Short-Term Debt issuances plummeted by 10000.5% in 2024 and then skyrocketed by 1661600.0% in 2025.
  • Quarter analysis of 3 years shows Amphastar Pharmaceuticals' Short-Term Debt issuances stood at $500.0 million in 2023, then tumbled by 99.03% to $4.9 million in 2024, then plummeted by 96.47% to $172000.0 in 2025.
  • Its Short-Term Debt issuances stands at $172000.0 for Q3 2025, versus $4.1 million for Q2 2025 and $1.6 million for Q1 2025.